6/30/2023 46,700 shares $53,238.00 -30.0% 0.2% 0.5 $1.14
6/15/2023 66,700 shares $86,376.50 +1.2% 0.3% 0.7 $1.30
5/31/2023 65,900 shares $102,804.00 -22.8% 0.3% 0.3 $1.56
5/15/2023 85,400 shares
Each report shows OKYO shorts have covered.
OKYO hit $1.34 today.
The last 10 days the stock has been trending up.
Lets hope the shorts cover before they cause another 52 week high of $7.00
Recent OKYO News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2024 11:00:16 AM
- OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference • GlobeNewswire Inc. • 10/30/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/23/2024 11:00:28 AM
- OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain • GlobeNewswire Inc. • 10/23/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/16/2024 11:00:07 AM
- OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain • GlobeNewswire Inc. • 10/16/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/10/2024 11:00:08 AM
- OKYO Pharma Announces Chairman Acquires Shares • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2024 11:00:24 AM
- OKYO Pharma Announces Chairman Acquires Shares • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/27/2024 11:00:04 AM
- OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 01:00:29 PM
- OKYO Pharma CEO Interview to Air on Bloomberg TV • GlobeNewswire Inc. • 08/23/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 11:00:07 AM
- OKYO Pharma Announces Chairman Acquires Shares • GlobeNewswire Inc. • 08/23/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/21/2024 11:00:14 AM
- OKYO Pharma Announces Chairman Acquires Shares • GlobeNewswire Inc. • 08/21/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/15/2024 05:21:25 PM
- OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • GlobeNewswire Inc. • 08/15/2024 04:13:50 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:30:51 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/06/2024 11:00:33 AM
- OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use • GlobeNewswire Inc. • 08/06/2024 11:00:00 AM
- Form NT 20-F - Notification of inability to timely file Form 20-F • Edgar (US Regulatory) • 07/31/2024 09:00:29 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/11/2024 11:00:09 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM